Topics
More on Medicare & Medicaid

Low-value healthcare drops only marginally despite effort to curb practices

The study suggests continued payment reforms and increasing computer-based decision-support tools.

Jeff Lagasse, Associate Editor

Spending on low-value healthcare among fee-for-service Medicare recipients dropped only marginally from 2014 to 2018, despite both a national campaign to better educate clinicians and increasing use of payment revisions that discourage wasteful care, according to a new RAND Corporation study.

Three items accounted for two-thirds of the low-value care. One of these is prescribing opioids for acute back pain increased, despite a growing national awareness of the harms caused by the drugs and the role of this type of prescribing in fueling the nation's opioid crisis.

The proportion of study participants receiving any of 32 low-value services decreased from 36.3% in 2014 to 33.6% in 2018. Annual spending per 1,000 individuals on low-value care also decreased, from $52,766 to $46,922 from 2014 to 2018. 

HIMSS20 Digital

Learn on-demand, earn credit, find products and solutions. Get Started >>

The findings are published online in the journal JAMA Network Open.

WHAT'S THE IMPACT?

An estimated 10% to 20% of healthcare spending consists of low-value care, defined as patient services that offer no net clinical benefit in specific scenarios. These items include many common treatments, such as the prescribing of antibiotics for uncomplicated acute upper respiratory infections.

While low-value care increases costs for both patients and payers, it also is associated with harmful outcomes for patients. For example, about one in every 1,000 antibiotic prescriptions is associated with serious complications that require a patient to visit a hospital emergency department.

To address the problem, the American Board of Internal Medicine Foundation joined with multiple clinician specialty societies in 2012 to create an initiative called Choosing Wisely, designed to encourage physicians and patients to engage in conversations about evidence-based medical practice and the problem of low-value care.

The new RAND study analyzed information about the care received by more than 21 million Americans enrolled from 2014 to 2018 in traditional fee-for-service Medicare, the nation's health insurance program for people aged 65 years and older.

Researchers examined claims-based low-value care measures from the Milliman MedInsight Health Waste Calculator, a software program that highlights care designated as wasteful by the Choosing Wisely campaign and other professional physician society guidelines.

They found that three services accounted for two-thirds of the low-value care. In addition to opioids prescribed for back pain, the other two services were preoperative laboratory testing and the prescribing of antibiotics for upper respiratory infections.

During the study period, preoperative laboratory testing fell, while increases occurred among both opioid prescriptions for back pain and the prescribing of antibiotics for upper respiratory infections.

Researchers caution that the study reflects a small portion of unnecessary care that is amenable to measurement.

THE LARGER TREND

The study suggests that policymakers continue efforts to educate both physicians and patients about low-value care and continue with payment reforms that discourage use of the low-value practices. In addition, efforts should increase use of computer-based decision-support tools that can encourage physicians to reduce their use of low-value medical care.

In a 2017 study that honed in on the Commonwealth of Virginia, researchers analyzed 5.4 million of the 44 healthcare services included in the study received by Virginia beneficiaries and found that 1.7 million of them were low-value – which cost more than $586 million. That is equal to 2.1% of Virginia's healthcare costs, which totaled $28 billion that year.

Twitter: @JELagasse
Email the writer: jeff.lagasse@himssmedia.com